Overview
- 36 inspections across 35 sites are on record.
- 91 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-24.
At a glance
Inspections
36
Sites
35
Observations
91
Career since
Aug 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Oxalis Labs | 24 Apr 2026 | Human Drugs | View 483 → |
| Cipla Limited | 17 Apr 2026 | Human Drugs | On file |
| Fresenius Kabi USA, LLC | 13 Feb 2026 | Human Drugs | On file |
| Norwich Pharmaceuticals, Inc. | 17 Dec 2025 | Human Drugs | |
| Nifty Labs Private Limited | 25 Sep 2025 | Human Drugs | On file |
Sites inspected
Oxalis LabsSolan, India1 insp.
Cipla LimitedSalcette, India1 insp.
Fresenius Kabi USA, LLCWilson, United States1 insp.
Norwich Pharmaceuticals, Inc.Norwich, United States1 insp.
Nifty Labs Private LimitedKondapalle, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Amatul H Marium4 shared
Clinton J Lott3 shared
Karen A Briggs3 shared
Bijoy Panicker3 shared
Ankur C Patel2 shared
Anastasia M Shields2 shared
Adena S Yau2 shared
Raihan A Chowdhury2 shared
Adetutu M Gidado2 shared
Yvins Dezan1 shared
Full investigator report
Get the verbatim findings behind Karishma G Gopaul's 91 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site